(IN BRIEF) The European Investment Bank (EIB) has signed a €20 million loan agreement with Universal DX, a Spanish startup pioneering blood-based liquid biopsy solutions for early cancer detection. The investment will accelerate the development and commercialization of their colorectal, … Read the full press release
(IN BRIEF) Amadix, a Spanish biotech company focused on non-invasive blood tests for early cancer detection, has secured a €15 million loan from the European Investment Bank (EIB). This funding, backed by InvestEU, will support Amadix in advancing its blood … Read the full press release
Posted in Banks, Business, Economy, Environment, Financial, Healthcare, Industrial, Investment, Luxembourg, Management, News, Science, Spain, Technology
Tagged AI, Amadix, artificial intelligence, colorectal cancer, DiagnoLung, digitalization, early cancer detection, Early Detection, EIB, EU Beating Cancer Plan, European Investment Bank, European medtech startups, InvestEU, life sciences, liquid biopsy, miRNAs, non-invasive blood tests, PancreaDix, partnership, PreveCol, protein analysis, Rocío Arroyo, sustainability, technological innovation, U.S. market, Valladolid, €15 million loan
(IN BRIEF) In early 2024, Europe’s medical and research communities announced major breakthroughs in cancer care, highlighting new treatments like AstraZeneca and Daiichi Sankyo’s datopotamab deruxtecan for lung and breast cancer, and AstraZeneca’s Tagrisso for EGFR-mutated lung cancer. Diagnostic advancements … Read the full press release
Posted in Finland, Germany, Healthcare, Insurance, News, Pharma & Biotech, Science, Society, Switzerland, Technology, United Kingdom
Tagged accessible cancer solutions, AstraZeneca, Aviva, BioNTech, breast cancer, breast cancer screening, cancer care, cancer diagnostics, cancer prevention awareness, cancer research, cancer treatment, colorectal cancer, Daiichi Sankyo, datopotamab deruxtecan, Duality Biologics, Eckert & Ziegler, EMA, FDA, genetic risk information, Inspirna, lung cancer, Merck KGaA, multi-cancer early detection, neuroendocrine neoplasms diagnostics, Novartis, ompenaclid, oncology, polygenic risk score, preventive healthcare, Professor Tim Maughan, ReSisTrace methodology, Stage III EGFR-mutated lung cancer, Swiss Re Institute, Tagrisso, treatment-resistant cancer cells, University of Helsinki, University of Liverpool
(IN BRIEF) A study led by researchers at the University of Helsinki highlights the need for a more comprehensive approach to assessing the hereditary risk of colorectal cancer. By analyzing genetic data and health records of over 450,000 Finns, the … Read the full press release
Posted in Business, Education, Financial, Finland, Healthcare, Industrial, Investment, Management, News, Science, Technology
Tagged assessment, colorectal cancer, Dr. Nina Mars, Genetic Information, Max Tamlander, University of Helsinki
(IN BRIEF) Merck KGaA, Darmstadt, Germany, has entered into a licensing agreement with Inspirna, Inc. for ompenaclid (RGX-202), a first-in-class oral inhibitor of the creatine transport channel SLC6A8, and SLC6A8-targeting follow-on compounds, currently under Phase II evaluation for the second-line … Read the full press release
Posted in Business, Environment, Financial, Germany, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged colorectal cancer, Dr. Usman “Oz” Azam, ERBITUX, Inspirna, Merck KGaA, ompenaclid (RGX-202), partnership, sustainability, USA, Victoria Zazulina
SOUTHAMPTON, 02-Apr-2018 — /EuropaWire/ — Many patients receiving chemotherapy following surgery for bowel cancer may only need three months treatment rather than the six months currently given, new research published in Lancet Oncology has shown. An international clinical trial, funded by … Read the full press release
Posted in Education, Healthcare, Science, United Kingdom
Tagged Cancer, chemotherapy, colorectal cancer, Dr Tim Iveson, fluoropyrimidine, neuropathy, oxaliplatin
World’s first complete Sample to Insight NGS solution proves equal or better compared with other sequencing workflows and alternative technologies Austin, Texas, and Hilden, Germany, 6-11-2015 — /EuropaWire/ — QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced that an … Read the full press release
Posted in Germany, Healthcare, Netherlands, Pharma & Biotech
Tagged colorectal cancer, detecting gene variants, GeneReader NGS System, QIAGEN
Researchers from Faculty of Health and Medical Sciences, University of Copenhagen, have characterized a genetic aberration on a group of colorectal cancer patients. The discovery gives hope for a new and efficient treatment of colorectal cancer, which is a frequent … Read the full press release
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?